212 related articles for article (PubMed ID: 23407048)
1. The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity.
Ho HT; Wang TH; Hsiong CH; Perng WC; Wang NC; Huang TY; Jong YJ; Lu PL; Hu OY
Pharmacogenet Genomics; 2013 Apr; 23(4):200-7. PubMed ID: 23407048
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
4. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
[TBL] [Abstract][Full Text] [Related]
5.
Mohamed Noor NF; Salleh MZ; Mohd Zim MA; Bakar ZA; Fakhruzzaman Noorizhab MN; Zakaria NI; Lailanor MI; Teh LK
Pharmacogenomics; 2022 Jun; 23(9):531-541. PubMed ID: 35615896
[No Abstract] [Full Text] [Related]
6. tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.
Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Frías A; Visca M; Aidar O; Costa L; de Larrañaga GF
Pharmacogenet Genomics; 2016 Jul; 26(7):357-61. PubMed ID: 27104815
[TBL] [Abstract][Full Text] [Related]
7. Genomewide Association Study Confirming the Association of
Suvichapanich S; Wattanapokayakit S; Mushiroda T; Yanai H; Chuchottawon C; Kantima T; Nedsuwan S; Suwankesawong W; Sonsupap C; Pannarunothai R; Tumpattanakul S; Bamrungram W; Chaiwong A; Mahasirimongkol S; Mameechai S; Panthong W; Klungtes N; Munsoo A; Chauychana U; Maneerat M; Fukunaga K; Omae Y; Tokunaga K
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109976
[TBL] [Abstract][Full Text] [Related]
8. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
[TBL] [Abstract][Full Text] [Related]
9. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
[TBL] [Abstract][Full Text] [Related]
10. NAT2 Genotypes in Moroccan Patients with Hepatotoxicity Due to Antituberculosis Drugs.
Guaoua S; Ratbi I; El Bouazzi O; Hammi S; Tebaa A; Bourkadi JE; Bencheikh RS; Sefiani A
Genet Test Mol Biomarkers; 2016 Nov; 20(11):680-684. PubMed ID: 27541622
[TBL] [Abstract][Full Text] [Related]
11. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.
García-Closas M; Hein DW; Silverman D; Malats N; Yeager M; Jacobs K; Doll MA; Figueroa JD; Baris D; Schwenn M; Kogevinas M; Johnson A; Chatterjee N; Moore LE; Moeller T; Real FX; Chanock S; Rothman N
Pharmacogenet Genomics; 2011 Apr; 21(4):231-6. PubMed ID: 20739907
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
Ben Fredj N; Gam R; Kerkni E; Chaabane A; Chadly Z; Boughattas N; Aouam K
Pharmacogenomics J; 2017 Jul; 17(4):372-377. PubMed ID: 27089936
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
Araujo-Mariz C; Militão de Albuquerque MFP; Lopes EP; Ximenes RAA; Lacerda HR; Miranda-Filho DB; Lustosa-Martins BB; Pastor AFP; Acioli-Santos B
Ann Hepatol; 2020; 19(2):153-160. PubMed ID: 31734174
[TBL] [Abstract][Full Text] [Related]
14. NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
Wattanapokayakit S; Mushiroda T; Yanai H; Wichukchinda N; Chuchottawon C; Nedsuwan S; Rojanawiwat A; Denjanta S; Kantima T; Wongyai J; Suwankesawong W; Rungapiromnan W; Kidkeukarun R; Bamrungram W; Chaiwong A; Suvichapanich S; Mahasirimongkol S; Tokunaga K
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1364-1369. PubMed ID: 27725049
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity.
Sharma SK; Jha BK; Sharma A; Sreenivas V; Upadhyay V; Jaisinghani C; Singla R; Mishra HK; Soneja M
Indian J Med Res; 2016 Dec; 144(6):924-928. PubMed ID: 28474630
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis.
Cho HJ; Koh WJ; Ryu YJ; Ki CS; Nam MH; Kim JW; Lee SY
Tuberculosis (Edinb); 2007 Nov; 87(6):551-6. PubMed ID: 17950035
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic association between
Khan S; Mandal RK; Elasbali AM; Dar SA; Jawed A; Wahid M; Mahto H; Lohani M; Mishra BN; Akhter N; Rabaan AA; Haque S
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509962
[TBL] [Abstract][Full Text] [Related]
19. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
[TBL] [Abstract][Full Text] [Related]
20. Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.
Guaoua S; Ratbi I; Laarabi FZ; Elalaoui SC; Jaouad IC; Barkat A; Sefiani A
BMC Genet; 2014 Dec; 15():156. PubMed ID: 25544508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
